^
Association details:
Biomarker:BIRC3‐MALT1 fusion
Cancer:Lymphoma
Drug:MI-2 (Menin-MLL inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: D – Preclinical
Title:

Establishment and characterization of a MALT lymphoma cell line carrying an API2-MALT1 translocation

Published date:
04/29/2020
Excerpt:
...a novel lymphoma cell line named BMA19, carrying the API2‐MALT1 translocation from a patient...The MALT1 inhibitor MI‐2 specifically decreased cell growth, and the BMA19 cell line was suggested to be still dependent on the API2‐MALT1 signal.
DOI:
10.1002/gcc.22855